Phase 1 Study: Acapatamab in mCRPC. bit.ly/3WfDVkI

Phase 2b Study: Nicotinamide and EGFR-TKIs in EGFR-Mutated Adenocarcinoma. bit.ly/3QhfCiH

Clinical Study: Pooled safety analysis of the FGFR1–4 inhibitor futibatinib. bit.ly/3xX0rov

Phase 1b/2 Study: Vactosertib and imatinib combination for desmoid tumors.bit.ly/3UfsdnI

Antibody-Drug Conjugates: Advancing from magic bullet to biological missile. bit.ly/3QmlaID

IL-15 and IL-21: Better when membrane-tethered together on anti-tumor T cells. bit.ly/3Ud6A7r

🔎 Scientists evaluated the utility of tumor content in circulating cell-free 🧬 DNA for monitoring #HCC throughout its natural history.

They included 67 HBV-related HCC patients, of whom 17 had paired pre- and post-💉 treatment samples.

Clinical Cancer Research | bit.ly/3UnxsmC

Want to learn more about CMS4 #coloncancer ? Read our review just published in Clinical Cancer Research aacrjournals.org/clincancerres/… Centre de Recherche des Cordeliers SIRIC CARPEM Hôpital européen Georges-Pompidou AP-HP Université Paris Cité Laurent-Puig Julien Taieb

Here the paper aacrjournals.org/clincancerres/…
International Society of Liquid Biopsy

Grateful that our paper was selected for the inaugural Clinical Cancer Research early career award - Urvi Shah
AACR Memorial Sloan Kettering Cancer Center Marlowe S Tessmer Clinical Cancer Research AlexanderLesokhin MD Kylee Maclachlan Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰

#AACR24 #Cancer #OncoDaily #Oncology #Myeloma

oncodaily.com/47042.html

Biomarkers of Efficacy and Safety of the Academic BCMA-CART ARI0002h for the Treatment of Refractory Multiple Myeloma aacrjournals.org/clincancerres/…

Our latest review article in Clinical Cancer Research online ahead of print ➡️ New means and challenges in the targeting of BTK! 🙌 Check it out to get an update on #CLLsm #lymsm #leusm new drugs targeting BTK and new biology of BTKi resistance! #PrecisionOncology aacrjournals.org/clincancerres/…

Wonderful to see our #liquidbiopsies research highlighted in the #AACR24 #precisiononcology special series!

Read the open access Clinical Cancer Research study: aacrjournals.org/clincancerres/…

AACR Johns Hopkins Thoracic Oncology Johns Hopkins Medicine Lavanya Sivapalan Joseph Murray

Don't miss Editor-In-Chief Keith Flaherty wrap-up #AACR24 by featuring meeting highlights and the vision for the future. AACR

It’s a great honor to meet the editor Marlowe S Tessmer and editor-in-chief Keith Flaherty for Clinical Cancer Research , session in the books, #AACR24

If you want more from #AACR24 AR and prostate cancer session speaker Scott Dehm, be sure to read his recent coauthored paper on a similar topic. bit.ly/3VNTznj AACR

Just published at #AACR24 , Küçükosmanoglu, Bart Westerman et al. use adverse event data from the FDA Adverse Event Reporting System to identify patterns of toxicity in drug combinations. bit.ly/3VUoyy2 AACR

Hot off the press Clinical Cancer Research a 3-arm study in which women with CIN-2 or 3 are either observed, treated with intravaginal imiquimod, or treated with an HPV vaccine and imiquimod from Alessandro Santin, et al. Yale School of Medicine Yale Cancer Center. bit.ly/3vCR3FV AACR

Out today from Wael El-Rifai UMiami Health System who identifies SMAD3 as a promising therapeutic target for future combination strategies for the treatment of esophageal adenocarcinoma patients. bit.ly/3PXIc8F #AACR24 AACR